Effects of Fibrinogen on Lipid Peroxidation in Patients with Coronary Heart Disease and in Vitro

被引：0
|
作者：
A. P. Savchenkova
L. B. Dudnik
I. L. Pogoretskaya
N. P. Solov'eva
M. A. Pokrovskaya
A. V. Aseichev
S. V. Drinitsyna
O. A. Azizova
Yu. M. Lopukhin
机构：
[1] Institute of Physicochemical Medicine,Russian Ministry of Health
来源：
Bulletin of Experimental Biology and Medicine | 2003年 / 135卷
关键词：
fibrinogen; lipid peroxidation; blood plasma and serum; coronary heart disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In patients with coronary heart disease oxidizability of lipids during Cu2+-induced oxidation of blood plasma inversely correlated with fibrinogen content. A positive correlation was found between the amount of lipid peroxidation products in the plasma from these patients and fibrinogen content. The increase in fibrinogen content was associated with high levels of total lipids and triglycerides and low concentration of high-density lipoprotein cholesterol. In vitro experiments demonstrated that fibrinogen reduces oxidizability of blood plasma. Our results suggest that the decrease in lipid oxidizability at high concentration of fibrinogen in patients with coronary heart disease is related to predominant oxidation of fibrinogen and its competition with plasma lipids during Cu2+-induced oxidation.
引用
收藏
页码：29 / 33
页数：4
相关论文
共 50 条
  • [1] Effects of fibrinogen on lipid peroxidation in patients with coronary heart disease and in vitro
    Savchenkova, AP
    Dudnik, LB
    Pogoretskaya, IL
    Solov'eva, NP
    Pokrovskaya, MA
    Aseichev, AV
    Drinitsyna, SV
    Azizova, OA
    Lopukhin, YM
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 135 (01) : 29 - 33
  • [2] LIPID-PEROXIDATION AND HYPERURICEMIA IN PATIENTS WITH CORONARY HEART-DISEASE
    BARATS, SS
    SMOLENSKAYA, OG
    KARDIOLOGIYA, 1990, 30 (04) : 51 - 54
  • [3] Hyperhomocysteinemia and lipid peroxidation in stable coronary heart disease
    Belaya, O. L.
    Fedorova, N. V.
    Fomina, I. G.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (01): : 41 - 46
  • [4] THE CORRECTION OF MICROCIRCULATION AND LIPID PEROXIDATION IN PATIENTS WITH PEPTIC ULCER IN COMBINATION WITH CORONARY HEART DISEASE
    Petrushov, A., V
    WORLD OF MEDICINE AND BIOLOGY, 2010, 26 (03): : 108 - 112
  • [5] Lipid Peroxidation Product and Glutathione Levels in Patients with Coronary Heart Disease Before and After Surgery
    Khansha, Rahman
    Miladpour, Behnoosh
    Mostafavi-Pour, Zohreh
    Zal, Fatemeh
    GALEN MEDICAL JOURNAL, 2015, 4 (02): : 78 - 82
  • [6] Homocysteine, lipid peroxidation products, and total antioxidant status in patients with coronary heart disease.
    Piechota, W
    Józefczak, E
    Bejm, J
    Wadowska, E
    Tkaczewski, K
    CLINICAL CHEMISTRY, 1999, 45 (06) : A14 - A15
  • [7] IMPACT OF TRANSVENOUS LASER THERAPY ON LIPID-PEROXIDATION IN PATIENTS WITH CORONARY HEART-DISEASE
    VAKHLYAYEV, VD
    SMIRNOVA, IY
    UCHAIKINA, LV
    BARSEL, VA
    AKSYUTINA, MS
    MATVEYEVA, SA
    PARAMONOVA, MA
    SHCHEDRINA, IS
    SYRKIN, AL
    KARDIOLOGIYA, 1992, 32 (7-8) : 43 - 45
  • [8] Fibrinogen is a predictor of mortality in coronary heart disease patients
    Benderly, M
    Graff, E
    ReicherReiss, H
    Behar, S
    Brunner, D
    Goldbourt, U
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (03) : 351 - 356
  • [9] The state of lipid peroxidation system in patients with ischemic heart disease
    Barsel, VA
    Tschedrina, IS
    Vakhlyaev, VD
    Aksyutina, MS
    Paramonova, MA
    Yuditchev, IS
    Syrkin, AL
    KARDIOLOGIYA, 1998, 38 (05) : 18 - 20
  • [10] Positive effect of EIFITOL on the blood lipid spectrum and fibrinogen level in patients with coronary heart disease (CHD)
    Lyutova, L
    Panchenko, V
    Isaev, V
    Cherdakova, N
    Andreenko, G
    Karabasova, M
    Naslyhanyan, S
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1341 - P1341
12345